A detailed history of Pathstone Holdings, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Pathstone Holdings, LLC holds 3,148 shares of HAE stock, worth $226,718. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,148
Previous 2,491 26.37%
Holding current value
$226,718
Previous $212,000 22.64%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$81.24 - $97.37 $53,374 - $63,972
657 Added 26.37%
3,148 $260,000
Q1 2024

May 13, 2024

SELL
$71.24 - $85.35 $52,218 - $62,561
-733 Reduced 22.74%
2,491 $212,000
Q4 2023

Feb 14, 2024

BUY
$80.59 - $92.61 $259,822 - $298,574
3,224 New
3,224 $275,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.7B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.